Target intelligence / Profile preview

Human intestinal microbiota

Molecular classification
Other
01

Overview

The **human intestinal microbiota** refers to the diverse community of microorganisms—including bacteria, archaea, fungi, and viruses—that reside within the human gastrointestinal (GI) tract, primarily the large intestine[1][2][3][5]. This ecosystem contributes key functions to host physiology, including fermentation of otherwise indigestible dietary components, synthesis of vitamins, protection against pathogenic microbes, shaping of the immune system, energy harvest, and maintenance of intestinal barrier integrity[1][2][3]. The microbiota is predominantly composed of bacteria from the phyla Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria, comprising hundreds of distinct species, with proportions varying between individuals and across life stages or disease states[1][2][3][5]. Dysbiosis, or imbalance in the microbial community, has been implicated in a range of diseases—including inflammatory, metabolic, autoimmune, and infectious conditions—prompting research and therapeutic interest in approaches such as probiotics, prebiotics, antibiotics, and fecal microbiota transplantation[1][2][3]. Importantly, the human intestinal microbiota is a **complex biological community** rather than a single molecular entity or canonical drug target, so it does not fit traditional definitions of receptor, enzyme, transporter, etc., but instead is a dynamic multicellular ecosystem with wide-ranging systemic effects[1][2][3].

Other names
Human gut microbiotaHuman gut floraHuman intestinal floraHuman intestinal microbiomeGut microbiome
02

Mechanism of action

Modulation of microbial composition and diversity. Restoration of eubiosis (microbial balance) or disruption (dysbiosis). Alteration of short-chain fatty acid production. Regulation of host immune responses. Enhancement of colonization resistance to pathogens.

03

Biological functions

Fermentation of undigested carbohydrates and fiberProduction of short-chain fatty acids (SCFAs)Vitamin synthesis (e.g., B vitamins, vitamin K)Metabolism of bile acids and xenobioticsDevelopment and regulation of host immune systemMaintenance of intestinal epithelial barrierProtection against pathogensModulation of host metabolism and energy balanceModulation of the gut–brain axis
04

Disease associations

InflammationInfectionMetabolic disorders (e.g., obesity, type 2 diabetes)Cardiovascular diseaseNeurodegenerative diseaseAutoimmune diseaseCancerOther
05

Safety considerations

Risk of infection from perturbing microbiota (e.g., FMT transferring pathogens)Antibiotic-associated dysbiosis and opportunistic infectionUnintended immune modulationUnpredictability of individual responses
06

Interacting drugs

Probiotics (live beneficial microorganisms)

3 more in the full profile.

07

Biomarkers

Microbial diversity indices (e.g., Shannon index)Relative abundance of specific taxa (e.g., Firmicutes/Bacteroidetes ratio)Fecal short-chain fatty acidsPresence of pathogenic bacteria (e.g., Clostridioides difficile)Metabolite profiles (metabolomics)

Beyond the preview

Go deeper on Human intestinal microbiota.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human intestinal microbiota.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call